Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ · Healthcare
Zentalis Pharmaceuticals, Inc. Operating Income 2022–2025
Zentalis Pharmaceuticals, Inc. annual/quarterly operating income history and growth rate from 2022 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Zentalis Pharmaceuticals, Inc. operating income for the quarter ending September 30, 2025 was -33.7 M, a 34.41% decrease year-over-year.
- Zentalis Pharmaceuticals, Inc. operating income for the twelve months ending September 30, 2025 was -166.8 M, a 34.96% decrease year-over-year.
- Zentalis Pharmaceuticals, Inc. annual operating income for 2025 was -152.8 M, a 20.08% decrease from 2024.
- Zentalis Pharmaceuticals, Inc. annual operating income for 2024 was -191.2 M, a 36.16% decrease from 2023.
- Zentalis Pharmaceuticals, Inc. annual operating income for 2023 was -299.5 M, a 31.78% increase from 2022.
- Zentalis Pharmaceuticals, Inc. annual operating income for 2022 was -227.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Zentalis Pharmaceuticals, Inc. Operating Income — FAQ
Zentalis Pharmaceuticals, Inc. (ZNTL) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Zentalis Pharmaceuticals, Inc.'s operating income?
Zentalis Pharmaceuticals, Inc. (ZNTL) reported operating income of -$153M for fiscal 2025.
Where can I see ZNTL's operating income history?
The chart and table above show Zentalis Pharmaceuticals, Inc.'s operating income by year and by quarter, including the growth rate.